Suven Pharmaceuticals Limited (SUVENPHAR) — Free Cash Flow Generation Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs255.04 Million represents 1% of operating cash flow (Rs255.04 Million). Explore how much does Suven Pharmaceuticals Limited reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Suven Pharmaceuticals Limited across 7 annual periods. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited operating cash flow efficiency.
Annual Free Cash Flow Generation for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Free Cash Flow Generation Index for Suven Pharmaceuticals Limited. Check SUVENPHAR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | Rs1.32 Billion | Rs2.88 Billion | Rs1.56 Billion | ▼ -46.3% |
| 2024 | 0.86x | Rs3.07 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +133.6% |
| 2023 | 0.37x | Rs1.65 Billion | Rs4.51 Billion | Rs2.86 Billion | ▼ -52.6% |
| 2022 | 0.77x | Rs2.55 Billion | Rs3.30 Billion | Rs751.87 Million | ▲ +8.6% |
| 2021 | 0.71x | Rs2.73 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -6.6% |
| 2020 | 0.76x | Rs3.17 Billion | Rs4.16 Billion | Rs994.15 Million | ▲ +701.1% |
| 2019 | -0.13x | Rs-63.81 Million | Rs504.05 Million | Rs567.86 Million | — |